Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Research Letter

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023

Mike J. Mwanga1, Arnold W. Lambisia1, John Mwita Morobe1, Nickson Murunga1, Edidah Moraa, Leonard Ndwiga, Robinson Cheruiyot, Jennifer Musyoki, Martin Mutunga, Laura M. Guzman-Rincon, Charles Sande, Joseph Mwangangi, Philip Bejon, Lynette Isabella Ochola-Oyier, D. James Nokes, Charles N. Agoti, Joyce Nyiro, and George GithinjiComments to Author 
Author affiliations: Kenya Medical Research Institute Wellcome Trust Research Programme, Kilifi, Kenya (M.J. Mwanga, A.W. Lambisia, J.M. Morobe, N. Murunga, E. Moraa, L. Ndwiga, R. Cheruiyot, J. Musyoki, M. Mutanga, C. Sande, J. Mwangangi, P. Bejon, L.I. Ochola-Oyier, D.J. Nokes, C.N. Agoti, J. Nyiro, G. Githinji); University of Warwick, Coventry, UK (L.M. Guzman-Rincon, D.J. Nokes); Pwani University, Kilifi (C.N. Agoti, G. Githinji)

Main Article

Table

Clinical signs and symptoms for patients infected with SARS-CoV-2 Omicron FY.4 variant with spike protein mutation Y451H, Kilifi Health Demographic Surveillance System, Kilifi, Kenya, January–May 2023*

Signs/symptoms No. (%) patients
Fever
Yes 57 (78.1)
No
 16 (21.9)
Cough
Yes 72 (98.6)
No
 1 (1.4)
Nasal discharge
Yes 54 (74.0)
No
 19 (26.0)
Difficulty breathing
Yes 5 (6.8)
No
 68 (93.2)
Sore throat
Yes 28 (38.4)
No
 45 (61.6)
Body malaise
Yes 25 (34.2)
No
 48 (65.8)
Conscious level
Alert
 73 (100.0)
COVID-19 vaccination status
Yes 12 (16.4)
No 60 (82.2)
No data
 1 (1.4)
COVID19 vaccine doses
1 3 (4.1)
2 7 (9.6)
No data 63 (86.3)

*Total number of patients was 73.

Main Article

1These authors contributed equally to this article.

Page created: August 31, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external